Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy

BACKGROUND: In recent years, a plethora of therapeutic agents for ulcerative colitis (UC), especially novel biologics (Bio), have become available. Although it is now possible to use biological drugs, there should be no need for frequently changing medications. To avoid first-pass metabolism in the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Med Sci Monit
Hauptverfasser: Shibuya, Tomoyoshi, Nomura, Kei, Okahara, Koki, Haga, Keiichi, Nomura, Osamu, Murakami, Takashi, Uchida, Shino, Kodani, Tomohiro, Ishikawa, Dai, Sakamoto, Naoto, Ogihara, Tatsuo, Osada, Taro, Nagahara, Akihito
Format: Artigo
Sprache:Inglês
Veröffentlicht: International Scientific Literature, Inc. 2019
Schlagworte:
Clinical Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6939661/
https://ncbi.nlm.nih.gov/pubmed/31865359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.918562
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge